Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen

• Status: Completed
• Trial end date: 2001-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study is designed to evaluate the potential beneficial effects of estrogen on cognitive function of women with Alzheimer's Disease.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: US Department of Veterans Affairs; VA Office of Research and Development
• Treatments: Estrogens

Criteria

• Post menopausal women with alzheimer's disease

• free of any major medical or neurological disease,

• medically safe to be treated with estrogen.